FrancophonIA/ELRC3.0 huggingface dataset:
English: abdominal pain, indigestion, constipation, passing wind, bloating, loose stools - Bile duct disorders, yellowing of the skin due to liver problems, liver tissue damage and inflammation of the liver - Itching, rash, hair loss, acne, increased sweating - Pain in joints, limbs, back and feet, muscle spasms - Insufficient function of the kidneys, reduced production of urine, impaired or painful urination - General weakness, fever, collection of fluid in your body, pain and discomfort, increase of the enzyme alkaline phosphatase in your blood, weight gain, feeling of temperature disturbed - Insufficient function of your transplanted organ
Slovenian: bolečina v trebuhu, prebavne motnje, zaprtje, vetrovi, napenjanje, mehko blato, - bolezni žolčevoda, porumenelost kože zaradi težav z jetri, okvara jetrnega tkiva in vnetje jeter, - srbenje, izpadanje las, akne, čezmerno znojenje, - bolečine v sklepih, udih, hrbtu ali stopalih, mišični krči, - nezadostno delovanje ledvic, zmanjšano nastajanje urina, oslabljeno ali boleče uriniranje, - splošna oslabelost, povišana telesna temperatura, zastajanje tekočin v telesu, bolečine in nelagodje, zvišanje alkalne fosfataze v krvi, povečanje telesne mase, moteno občutenje temperature,
English: Teva Gyógyszergyár Zrt Tel: +36 12886400
Slovenian: Tel: +36 12886400
English: Tacforius 0.5 mg / 1 mg / 3 mg prolonged-release hard capsules: red iron oxide (E172), yellow iron oxide (E172), titanium dioxide (E171), gelatin.
Slovenian: Tacforius 0,5 mg/1 mg/3 mg trde kapsule s podaljšanim sproščanjem: rdeči železov oksid (E172), rumeni železov oksid (E172), titanov dioksid (E171), želatina.
English: In de novo kidney and liver transplant patients AUC0-24 of tacrolimus for the prolonged-release capsules on Day 1 was 30% and 50% lower respectively, when compared with that for the immediate release capsules at equivalent doses.
Slovenian: V primerjavi z uporabo ekvivalentnih odmerkov kapsul s takojšnjim sproščanjem je bila vrednost AUC0-24 takrolimusa na 1. dan uporabe kapsul s podaljšanim sproščanjem pri bolnikih z na novo presajeno ledvico manjša za 30 %, pri bolnikih z na novo presajenimi jetri pa za 50 %.
English: As tacrolimus is a substance with low clearance, following adjustments to the Tacforius dose regimen it may take several days before the targeted steady state is achieved.
Slovenian: Takrolimus je učinkovina z majhnim očistkom, zato lahko po prilagoditvi odmerka zdravila Tacforius vzpostavitev ciljnega ravnovesnega stanja traja več dni.
English: hypoacusis rare:
Slovenian: hipertenzija pogosti:
English: Tacforius 1 mg prolonged-release hard capsules EU/1/17/1244/007
Slovenian: Tacforius 1 mg trde kapsule s podaljšanim sproščanjem EU/1/17/1244/007
English: Tacforius 0.5 mg / 3 mg / 5 mg prolonged-release hard capsules Pack sizes: 30, 50 and 100 prolonged-release hard capsules in blisters or 30x1, 50x1 and 100x1 prolonged-release hard capsules in perforated unit-dose blisters.
Slovenian: Zdravilo Tacforius 0,5 mg/3 mg/5 mg trde kapsule s podaljšanim sproščanjem Velikost pakiranja: 30, 50 in 100 trdih kapsul s podaljšanim sproščanjem v pretisnih omotih s 30x1,
English: TEVA GmbH Tel: +49 73140208
Slovenian: Tél/Tel: +49 73140202
English: Patients receiving immunosuppressive therapy are at increased risk of developing malignancies.
Slovenian: Benigne, maligne in neopredeljene novotvorbe Bolnike, ki prejemajo imunosupresive, bolj ogroža pojav malignomov.
English: Metabolism and nutrition disorders very common: diabetes mellitus, hyperglycaemic conditions, hyperkalaemia common:
Slovenian: diabetes mellitus, hiperglikemična stanja, hiperkaliemija pogosti:
English: Tacforius 0.5 mg / 1 mg prolonged-release hard capsules 2 years
Slovenian: Tacforius 0,5 mg/1 mg trde kapsule s podaljšanim sproščanjem2 leti
English: Common side effects (may affect up to 1 in 10 people) - Reduction in blood cell counts (platelets, red or white blood cells), increase in white blood cell counts, changes in red blood cell counts (seen in blood tests) - Reduced magnesium, phosphate, potassium, calcium or sodium in the blood, fluid overload,
Slovenian: Pogosti neželeni učinki (pojavijo se lahko pri največ 1 od 10 bolnikov) - zmanjšanje števila krvnih celic (trombocitov, rdečih ali belih krvnih celic), povečanje števila belih krvnih celic, spremembe v številu rdečih krvnih celic (razvidno iz preiskav krvi), - zmanjšanje koncentracije magnezija, fosfatov, kalija, kalcija ali natrija v krvi, preobremenitev s tekočino, povečana koncentracija sečne kisline ali lipidov v krvi, zmanjšanje apetita, zvečana kislost krvi, druge spremembe elektrolitov v krvi (razvidno iz preiskav krvi), - simptomi tesnobe, zmedenost in dezorientiranost, depresija, motnje razpoloženja, nočne more,
English: and combination tablets, used to treat HIV infection - HCV protease inhibitors (e.g. telaprevir, boceprevir and the combination ombitasvir/paritaprevir/ritonavir with or without dasabuvir), used to treat hepatitis C infection - nilotinib and imatinib (used to treat certain cancers) - mycophenolic acid, used to suppress the immune system to prevent transplant rejection - medicines for stomach ulcer and acid reflux (e.g. omeprazole, lansoprazole or cimetidine) - antiemetics, used to treat nausea and vomiting (e.g. metoclopramide) - cisapride or the antacid magnesium-aluminium-hydroxide, used to treat heartburn - the contraceptive pill or other hormone treatments with ethinylestradiol, hormone treatments with danazol - medicines used to treat high blood pressure or heart problems (e.g. nifedipine, nicardipine,
Slovenian: - zaviralci proteaz HIV (npr. ritonavir, nelfinavir, sakvinavir), stopnjevalno zdravilo kobicistat in kombinirane tablete, ki se uporabljajo za zdravljenje okužbe s HIV, - zaviralci proteaz HCV (npr. telaprevir, boceprevir in kombinacija ombitasvir/paritaprevir/ritonavir z dasabuvirjem ali brez njega), ki se uporabljajo za zdravljenje okužbe s hepatitisom C, - nilotinib in imatinib (ki se uporabljata za zdravljenje določenih vrst raka), - mikofenolna kislina, ki se uporablja za zavrtje imunskega sistema za preprečevanje zavrnitve presadkov, - zdravila za zdravljenje želodčne razjede in refluksa kislega želodčnega soka (npr. omeprazol,
English: Tacforius 0.5 mg prolonged-release hard capsules Hard gelatin capsules imprinted with “TR” on the light yellow capsule cap and “0.5 mg” on the light orange capsule body.
Slovenian: Tacforius 0,5 mg trde kapsule s podaljšanim sproščanjem Želatinske kapsule, ki imajo na svetlo rumenem pokrovčku odtisnjeno oznako “TR”, na svetlo oranžnem telesu kapsule pa oznako “0.5 mg”.
English: Tacforius 3 mg prolonged-release hard capsules EU/1/17/1244/015
Slovenian: Tacforius 3 mg trde kapsule s podaljšanim sproščanjem EU/1/17/1244/015
English: When converting from tacrolimus immediate release capsules to Tacforius prolonged-release capsules, trough levels should be measured prior to conversion and within two weeks after conversion.
Slovenian: Pred zamenjavo in v roku dveh tednov po zamenjavi kapsul takrolimusa s takojšnjim sproščanjem s kapsulami takrolimusa s podaljšanim sproščanjem je treba izmeriti najnižje koncentracije takrolimusa.
English: Prophylaxis of liver transplant rejection
Slovenian: Profilaksa zavrnitve ledvičnega presadka
English: Tacforius 5 mg prolonged-release hard capsules EU/1/17/1244/021
Slovenian: Tacforius 5 mg trde kapsule s podaljšanim sproščanjem EU/1/17/1244/021
English: The oral bioavailability of tacrolimus prolonged-release capsules was reduced when it was administered after a meal.
Slovenian: Pri peroralni uporabi kapsul takrolimusa s podaljšanim sproščanjem po jedi se je njegova biološka uporabnost zmanjšala.
English: Teva Pharmaceuticals S.R.L Tel: +40 212306524
Slovenian: Tel: +40 212306524
English: 12-month graft survival was 91.5% for tacrolimus prolonged-release capsules and 92.8% for tacrolimus immediate release capsules.
Slovenian: Pri uporabi kapsul takrolimusa s podaljšanim sproščanjem je bilo 12-mesečno preživetje presadka 91,5-odstotno, pri uporabi kapsule takrolimusa s takojšnjim sproščanjem pa 92,8-odstotno.
English: hallucination, mental disorders - Fits, disturbances in consciousness, tingling and numbness (sometimes painful) in the hands and feet, dizziness, impaired writing ability, nervous system disorders - Blurred vision, increased sensitivity to light, eye disorders - Ringing sound in your ears - Reduced blood flow in the heart vessels, faster heartbeat - Bleeding, partial or complete blocking of blood vessels, reduced blood pressure - Shortness in breath, disorders of the respiratory tissues in the lung, collection of liquid around the lung, inflammation of the pharynx, cough, flu-like symptoms - Stomach problems such as inflammation or ulcer causing abdominal pain or diarrhoea, bleeding in the stomach, inflammation or ulcer in the mouth, collection of fluid in the belly, vomiting,
Slovenian: halucinacije, duševne motnje, - epileptični napadi, motnje zavesti, mravljinčenje in odrevenelost (včasih boleča) v rokah in nogah, omotica, zmanjšana sposobnost za pisanje, bolezni živčevja, - zamegljen vid, preobčutljivost za svetlobo, očesne bolezni, - zvenenje v ušesih, - zmanjšan pretok krvi skozi srčne žile, hitrejši srčni utrip, - krvavitve, delna ali popolna zapora krvnih žil, znižan krvni tlak, - zasoplost, bolezni parenhimskega tkiva v pljučih, nabiranje tekočine okrog pljuč, vnetje žrela,
English: Tacforius 0.5 mg / 3 mg / 5 mg prolonged-release hard capsules Supplied in blisters or perforated unit-dose blisters containing 10 capsules within a protective foil pouch, including a desiccant.
Slovenian: Zdravilo Tacforius 0,5 mg/3 mg/5 mg trde kapsule s podaljšanim sproščanjem Na voljo so v pretisnih omotih ali perforiranih pretisnih omotih s posameznimi odmerki, ki vsebujejo 10 kapsul.
English: Each capsule of Tacforius 0.5 mg contains 0.5 mg of tacrolimus (as monohydrate).
Slovenian: Ena kapsula zdravila Tacforius 0,5 mg vsebuje 0,5 mg takrolimusa (v obliki monohidrata).
English: Benign as well as malignant neoplasms including EBV-associated lymphoproliferative disorders and skin malignancies have been reported in association with tacrolimus treatment.
Slovenian: V povezavi z zdravljenjem s takrolimusom so poročali o benignih in malignih novotvorbah, vključno z limfoproliferativnimi boleznimi, povezanimi z EBV, in kožnimi malignomi.
English: Herbal preparations containing St. John's Wort (Hypericum perforatum) or other herbal preparations should be avoided when taking tacrolimus due to the risk of interactions that lead to either a decrease in blood concentrations of tacrolimus and reduced clinical effect of tacrolimus, or an increase in blood concentrations of tacrolimus and risk of tacrolimus toxicity (see section 4.5).
Slovenian: Obstaja namreč nevarnost za medsebojno delovanje, ki zniža koncentracijo takrolimusa v krvi in zmanjša njegov klinični učinek ali zviša koncentracijo takrolimusa v krvi in tveganje za njegovo toksičnost (glejte poglavje 4.5).
English: Teva B.V.
Slovenian: Nederland Teva Nederland B.V.
English: EU/1/17/1244/018 EU/1/17/1244/019 EU/1/17/1244/020
Slovenian: EU/1/17/1244/001 EU/1/17/1244/002 EU/1/17/1244/003 EU/1/17/1244/004 EU/1/17/1244/005 EU/1/17/1244/006
English: hirsutism
Slovenian: Dojenje
English: pancreatic pseudocyst, subileus Hepatobiliary disorders common:
Slovenian: psevdocista pankreasa, subileus Bolezni jeter, žolčnika in žolčevodov pogosti:
English: Prolonged-release hard capsule
Slovenian: trda kapsula s podaljšanim sproščanjem
English: Your doctor will usually reduce your Tacforius dose once your condition has stabilised.
Slovenian: Ko se bo vaše stanje ustalilo, bo zdravnik odmerek zdravila Tacforius verjetno zmanjšal.
English: Allergic and anaphylactoid reactions have been observed in patients receiving tacrolimus (see section
Slovenian: Pri bolnikih, ki so dobivali takrolimus, so opisane alergijske in anafilaktoidne reakcije (glejte poglavje 4.4).
English: Each capsule of Tacforius 1 mg contains 1 mg of tacrolimus (as monohydrate).
Slovenian: Ena kapsula zdravila Tacforius 1 mg vsebuje 1 mg takrolimusa (v obliki monohidrata).
English: Both the rate and extent of absorption of tacrolimus prolonged-release capsules were reduced when administered with food.
Slovenian: Pri uporabi kapsul takrolimusa s podaljšanim sproščanjem skupaj s hrano sta se zmanjšala tako hitrost kot obseg absorpcije.
English: Pack sizes: 30, 50, 60 and 100 prolonged-release hard capsules in blisters or 30x1, 50x1, 60x1 and 100x1 prolonged-release hard capsules in perforated unit-dose blisters.
Slovenian: Velikost pakiranja: 30, 50, 60 in 100 trdih kapsul s podaljšanim sproščanjem v pretisnih omotih ali 30x1, 50x1, 60x1 in 100x1 trdih kapsul s podaljšanim sproščanjem v perforiranih pretisnih omotih za eposamezni odmerek.
English: Each capsule of Tacforius 5 mg contains 5 mg of tacrolimus (as monohydrate).
Slovenian: Ena kapsula zdravila Tacforius 5 mg vsebuje 5 mg takrolimusa (v obliki monohidrata).
English: Each capsule of Tacforius 3 mg contains 3 mg of tacrolimus (as monohydrate).
Slovenian: Ena kapsula zdravila Tacforius 3 mg vsebuje 3 mg takrolimusa (v obliki monohidrata).
English: Packs of 30, 50, 60 and 100 prolonged-release capsules are available in blisters and packs of 30x1, 50x1, 60x1 and 100x1 prolonged-release capsules are available in perforated unit-dose blisters.
Slovenian: Na voljo so pakiranja s 30, 50, 60 in 100 kapsulami s podaljšanim sproščanjem v pretisnih omotih ali 30x1, 50x1, 60x1 in 100x1 kapsulami s podaljšanim sproščanjem v perforiranih pretisnih omotih s posameznimi odmerki.
English: Very common side effects (may affect more than 1 in 10 people) - Increased blood sugar, diabetes mellitus, increased potassium in the blood - Difficulty in sleeping - Trembling, headache - Increased blood pressure - Liver function tests abnormal - Diarrhoea, nausea - Kidney problems
Slovenian: Zelo pogosti neželeni učinki (pojavijo se lahko pri več kot 1 od 10 bolnikov) - zvišana koncentracija glukoze v krvi, sladkorna bolezen, zvišana koncentracija kalija v krvi, - težave s spanjem,
English: Mycophenolic acid.
Slovenian: ALUMINIJASTI OVOJ
English: Tacforius 1 mg prolonged-release hard capsules Each prolonged-release hard capsule contains 1 mg tacrolimus (as monohydrate).
Slovenian: Tacforius 1 mg trde kapsule s podaljšanim sproščanjem Ena trda kapsula s podaljšanim sproščanjem vsebuje 1 mg takrolimusa (v obliki monohidrata).
English: Tacrolimus immediate release capsules (e.g, Tacni) and Tacforius prolonged-release capsules both contain the active substance, tacrolimus.
Slovenian: Tako kapsule takrolimusa s takojšnjim sproščanjem (npr. zdravilo Tacni) kot kapsule zdravila Tacforius s podaljšanim sproščanjem vsebujejo učinkovino takrolimus.
English: Packs of 30, 50 and 100 prolonged-release hard capsules are available in blisters and packs of 30x1, 50x1 and 100x1 prolonged-release capsules are available in perforated unit-dose blisters.
Slovenian: Na voljo so pakiranja s 30, 50 in 100 kapsulami s podaljšanim sproščanjem v pretisnih omotih in pakiranji s 30x1, 50x1 in 100x1 kapsulami s podaljšanim sproščanjem v perforiranih pretisnih omotih s posameznimi odmerki.
English: Tacforius 3 mg prolonged-release hard capsules Each prolonged-release hard capsule contains 3 mg tacrolimus (as monohydrate).
Slovenian: Tacforius 3 mg trde kapsule s podaljšanim sproščanjem Ena trda kapsula s podaljšanim sproščanjem vsebuje 3 mg takrolimusa (v obliki monohidrata).
English: Tacforius 5 mg prolonged-release hard capsules Each prolonged-release hard capsule contains 5 mg tacrolimus (as monohydrate).
Slovenian: Tacforius 5 mg trde kapsule s podaljšanim sproščanjem Ena trda kapsula s podaljšanim sproščanjem vsebuje 5 mg takrolimusa (v obliki monohidrata).
English: The 12-month patient survival rates were 96.9% for tacrolimus prolonged-release capsules and 97.5% for tacrolimus immediate release capsules; in the tacrolimus prolonged-release capsules arm 10 patients died (3 female, 7 male) and in the tacrolimus immediate release capsules arm 8 patients died (3 female, 5 male).
Slovenian: V skupini, ki je prejemala kapsule takrolimusa s podaljšanim sproščanjem, je umrlo 10 bolnikov (3 ženske, 7 moških), v skupini, ki je prejemala kapsule takrolimusa s takojšnjim sproščanjem, pa 8 bolnikov (3 ženske, 5 moških).
English: Torsades de Pointes Vascular disorders very common: hypertension common:
Slovenian: hirzutizem Presnovne in prehranske motnje zelo pogosti:
English: Tacforius 1 mg prolonged-release hard capsules
Slovenian: Tacforius 1 mg trde kapsule s podaljšanim sproščanjem
English: Tacforius 0.5 mg / 1 mg / 3 mg prolonged-release hard capsules Red iron oxide (E172)
Slovenian: Tacforius 0,5 mg/1 mg/3 mg trde kapsule s podaljšanim sproščanjem rdeči železov oksid (E172) rumeni železov oksid (E172) titanov dioksid (E171) želatina
English: Liver transplantation
Slovenian: Presaditev ledvic
English: Tacforius 0.5 mg prolonged-release hard capsules
Slovenian: Tacforius 0,5 mg trde kapsule s podaljšanim sproščanjem
English: - if you are allergic to sirolimus or to any macrolide-antibiotic (e.g. erythromycin, clarithromycin, josamycin).
Slovenian: Ne jemljite zdravila Tacforius: - če ste alergični na takrolimus ali katero koli sestavino tega zdravila (navedeno v poglavju 6), - če ste alergični na sirolimus ali na kateri koli makrolidni antibiotik (npr. eritromicin,
English: Tacforius 0.5 mg prolonged-release hard capsules Each prolonged-release hard capsule contains 0.5 mg tacrolimus (as monohydrate).
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Tacforius 0,5 mg trde kapsule s podaljšanim sproščanjem Ena trda kapsula s podaljšanim sproščanjem vsebuje 0,5 mg takrolimusa (v obliki monohidrata).
English: Tacforius 5 mg prolonged-release hard capsules
Slovenian: Tacforius 5 mg trde kapsule s podaljšanim sproščanjem takrolimus
English: Printing Ink
Slovenian: PRETISNI OMOT
English: Tacforius is not recommended for use in children below 18 years due to limited data on safety and/or efficacy.
Slovenian: Ker je na voljo le malo podatkov o varnosti in/ali učinkovitosti, uporaba zdravila Tacforius pri otrocih, mlajših od 18 let, ni priporočljiva.
English: psychotic disorder Nervous system disorders very common: headache, tremor common:
Slovenian: nevropatija vidnega živca Ušesne bolezni, vključno z motnjami labirinta pogosti:
English: Danmark
Slovenian: Finnland
English: Tacforius 0.5 mg prolonged-release hard capsules Tacforius 1 mg prolonged-release hard capsules Tacforius 3 mg prolonged-release hard capsules Tacforius 5 mg prolonged-release hard capsules
Slovenian: Tacforius 0,5 mg trde kapsule s podaljšanim sproščanjem Tacforius 1 mg trde kapsule s podaljšanim sproščanjem Tacforius 3 mg trde kapsule s podaljšanim sproščanjem Tacforius 5 mg trde kapsule s podaljšanim sproščanjem takrolimus
English: Skin and subcutaneous tissue disorders common:
Slovenian: odpoved jeter Bolezni kože in podkožja pogosti:
English: Teva Pharma Belgium N.V./S.A./AG Tél/Tel: +32 38207373
Slovenian: Tél/Tel: +32 38207373
English: The 12 - month patient survival rates were 98.6% for tacrolimus prolonged-release capsules, 95.7% for tacrolimus immediate release capsules and 97.6% for ciclosporin; in the tacrolimus prolonged-release capsules arm 3 patients died (all male), in the tacrolimus immediate release capsules arm 10 patients died (3 female, 7 male) and in the ciclosporin arm 6 patients died (3 female, 3 male).
Slovenian: V skupini, ki je prejemala kapsule takrolimusa s podaljšanim sproščanjem, so umrli 3 bolniki (vsi moškega spola), v skupini, ki je prejemala kapsule takrolimusa s takojšnjim sproščanjem, 10 bolnikov (3 ženske, 7 moških), v skupini,
English: Hard gelatin capsules imprinted with “TR” on the white capsule cap and “1 mg” on the light orange capsule body.
Slovenian: Tacforius 1 mg trde kapsule s podaljšanim sproščanjem Želatinske kapsule, ki imajo na belem pokrovčku odtisnjeno oznako “TR”, na svetlo oranžnem telesu kapsule pa oznako “1 mg”.
English: Tacforius 0.5 mg prolonged-release capsules Tacforius 1 mg prolonged-release capsules Tacforius 3 mg prolonged-release capsules Tacforius 5 mg prolonged-release capsules tacrolimus
Slovenian: Tacforius 0,5 mg kapsule s podaljšanim sproščanjem Tacforius 1 mg kapsule s podaljšanim sproščanjem Tacforius 3 mg kapsule s podaljšanim sproščanjem Tacforius 5 mg kapsule s podaljšanim sproščanjem takrolimus
English: Hard gelatin capsules imprinted with “TR” on the light orange capsule cap and “3 mg” on the light orange capsule body.
Slovenian: Tacforius 3 mg trde kapsule s podaljšanim sproščanjem Želatinske kapsule, ki imajo na svetlo oranžnem pokrovčku odtisnjeno oznako “TR”, na svetlo oranžnem telesu kapsule pa oznako “3 mg”.
English: A strong correlation exists between AUC and whole blood trough levels at steady-state for tacrolimus prolonged-release capsules.
Slovenian: Za takrolimus v farmacevtski obliki s podaljšanim sproščanjem obstaja močna korelacija med AUC in najnižjo koncentracijo v polni krvi v stanju dinamičnega ravnovesja.
English: PC SN NN
Slovenian: PC:
English: Uncommon side effects (may affect up to 1 in 100 people) - Changes in blood clotting, reduction in the number of all types of blood cells (seen in blood tests) - Dehydration, inability to urinate - Abnormal blood test results: reduced protein or sugar, increased phosphate, increase of the enzyme lactate dehydrogenase - Coma, bleeding in the brain, stroke, paralysis, brain disorder, speech and language abnormalities, memory problems - Clouding of the eye lens, impaired hearing - Irregular heartbeat, stop of heartbeat, reduced performance of your heart, disorder of the heart muscle, enlargement of the heart muscle, stronger heartbeat, abnormal ECG, heart rate and pulse abnormal - Blood clot in a vein of a limb, shock - Difficulties in breathing, respiratory tract disorders, asthma - Obstruction of the gut, increased blood level of the enzyme amylase, reflux of stomach content in your throat, delayed emptying of the stomach - Inflammation of the skin, burning sensation in the sunlight - Joint disorders - Painful menstruation and abnormal menstrual bleeding - Multiple organ failure, flu-like illness, increased sensitivity to heat and cold, feeling of pressure on your chest, jittery or abnormal feeling, weight loss
Slovenian: - krvni strdek v veni okončin, šok, - težave z dihanjem, bolezni dihal, astma, - zapora pretoka črevesne vsebine, povišane vrednosti encima amilaze v krvi, refluks želodčne vsebine v žrelo, upočasnjeno praznjenje želodca, - vnetje kože, pekoč občutek na sončni svetlobi, - težave s sklepi, - boleče menstruacije in nenormalna menstruacijska krvavitev, - odpoved več organov, gripi podobna bolezen, večja občutljivost za toplo in mrzlo, občutek tiščanja v prsih, živčnost ali nenormalno počutje, hujšanje.
English: What you need to know before you take Tacforius Do not take Tacforius
Slovenian: Kaj je zdravilo Tacforius in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Tacforius Kako jemati zdravilo Tacforius Možni neželeni učinki
English: OTHER
Slovenian: miastenija
English: Hard gelatin capsules imprinted with “TR” on the greyish red capsule cap and “5 mg” on the light orange capsule body.
Slovenian: Tacforius 5 mg trde kapsule s podaljšanim sproščanjem Želatinske kapsule, ki imajo na sivkasto rdečem pokrovčku odtisnjeno oznako “TR”, na svetlo oranžnem telesu kapsule pa oznako “5 mg”.
English: Supplied in blisters or perforated unit-dose blisters containing 10 capsules within a protective foil pouch, including a desiccant.
Slovenian: Pretisni omoti so obdani z zaščitnim ovojem iz folije, ki vsebuje tudi sušilno sredstvo.
English: See package leaflet for further information.
Slovenian: Opozorila so navedena v navodilu za uporabo.
English: Rare side effects (may affect up to 1 in 1,000 people) - Small bleedings in your skin due to blood clots - Increased muscle stiffness - Blindness, deafness - Collection of fluid around the heart - Acute breathlessness
Slovenian: Občasni neželeni učinki (pojavijo se lahko pri največ 1 od 100 bolnikov) - motnje strjevanja krvi, zmanjšanje števila vseh tipov krvnih celic (razvidno iz preiskav krvi), - dehidracija, nezmožnost uriniranja, - nenormalni izvidi preiskav krvi: zmanjšanje koncentracije beljakovin ali sladkorja, povečanje koncentracije fosfatov, povečanje encima laktat-dehidrogenaze,